lung Archives - AudioMedica.com

Tagged: lung

- in General Medicine
- — 21 Mar, 2008
Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer

Giorgio Scagliotti

Robert Pirker
GIORGIO SCAGLIOTTI, University of Turin
ROBERT PIRKER, Medical University of Vienna
A heated debate took place at the European Congress on Lung Cancer in Turin between Robert Pirker who is in favor of offering
…
Read more
- in Oncology
- — 17 Mar, 2008
Front Line Therapy in Non-Small Cell Lung Cancer

Nick Thatcher
NICK THATCHER, Christie Hospital, Manchester
There is a proven benefit in survival if you give your patients cis-platinum based chemotherapy after resection for non-small cell lung cancer. Nick Thatcher emphasized this fact at the beginning of his
…
Read more
- in General Medicine
- — 17 Mar, 2008
New Targets Bring Promise For Lung Cancer Therapy

Egbert Smit
EGBERT SMIT, Free University of Amsterdam
There are a number of promising new molecular targets for lung cancer chemotherapy which were discussed at the Turin congress by Egbert Smit. He talked with Peter Goodwin about insulin-like
…
Read more
- in General Medicine
- — 17 Mar, 2008
Target Angiogenesis for Lung Cancer With Multiple Tyrosine Kinase Inhibitors

Silvia Novello
SILVIA NOVELLO, University of Turin
Future improvements in drug treatment of lung cancer may be made by inhibiting more than one tyrosine kinase simultaneously. So said Silvia Novello when she presented data on a range of drugs
…
Read more
- in Oncology
- — 16 Mar, 2008
Bevacizumab: New Standard for Non-Small Cell Lung Cancer?

Christian Manegold

Nick Thatcher
Christian Manegold, Heidelberg University Medical Center, Manheim
Nick Thatcher, Christie Hospital, Manchester
Is bevacizumab a new standard of care for patients with unresectable non-small cell lung cancer who have good performance status? This question
…
Read more
- in News
- — 16 Mar, 2008
Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer

Robert Pirker
ROBERT PIRKER , Medical University of Vienna
Phase III study results have detected improvements in overall survival among patients with advanced non-small cell lung cancer treated with a monoclonal antibody targeted to the epidermal growth factor receptor: EGFR.
…
Read more
- in News
- — 16 Mar, 2008
Lung Cancer Screening: Wait for Prospective Study Findings!

Ugo Pastorino
UGO PASTORINO , Istituto Nazionale Tumori, Milan
Even the most sophisticated and powerful detection method for lung cancer detection, spiral CT, is still unproven in the context of mass screening for lung cancer. At the conference in Turin,
…
Read more
- in Oncology
- — 16 Nov, 2007
Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Jean-Yves Douillard

Gordon McVie
REFERENCE: Abstracts: 6507 & 2LB, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
JEAN-YVES DOUILLARD, Centre René Gauducheau, Nante
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan
The vinca alkaloid vinflunine and
…
Read more
- in Cardiovascular
- — 6 Nov, 2007
Protective Cardiovascular Benefit for Women on HRT For Natural Menopause

George Sopko

Jennifer Mieres’; }?
REFERENCE: Abstract 3771, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
N Engl J Med 2007;357
GEORGE SOPKO, National Heart, Lung And Blood Institute, Bethesda, Maryland
COMMENT: JENNIFER MIERES, New York University
A
…
Read more
- in Oncology
- — 16 Oct, 2007
Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

Jose Baselga

Gordon McVie
REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan
Neoadjuvant trastuzumab for patients with HER2-positive
…
Read more

in AJO · ASCO · Oncology
— 1 Dec, 2006

Audio Journal of Oncology in Advance – December 1st, 2006

Clifford Hudis

Mark Einstein

Tony Greco

James Berenson

Edward Ambinder

Breast Cancer: HER2 Still a Useful Target After Trastuzumab Resistance

REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006
CLIFFORD HUDIS, Memorial Sloan-Kettering Cancer Center, New York
COMMENT: EDWARD AMBINDER, Mount

…

in AJO · ASCO · Oncology
— 14 Oct, 2006

ASCO Audio Journal of Oncology in Advance – October 15th, 2006

Gordon McVie

Martine Piccart

Bella Kaufman

Jean-Yves Douillard

ESMO Congress Reviewed

GORDON MCVIE, European Institute of Oncology, Milan
In Istanbul, Gordon McVie gave his opinion about the achievements of the 2006 European Society for Medical Oncology Congress. He added his

…

Tagged: lung

Breast Cancer: HER2 Still a Useful Target After Trastuzumab Resistance

ESMO Congress Reviewed

Sign up for AudioMedica.com news